Genelux (GNLX) Current Leases (2022 - 2026)
Genelux (GNLX) recorded quarterly Current Leases of $316000.0 in Q1 2026, down 26.0% quarter-over-quarter from $427000.0 in Q4 2025.
Genelux (GNLX) Current Leases (2022 - 2026) Analysis & Trends
Genelux's Current Leases history runs 5 years deep, the most recent figure standing at $316000.0 for Q1 2026.
- In Q1 2026, Current Leases changed N/A year-over-year to $316000.0; the TTM figure through Mar 2026 stood at $316000.0 (changed N/A YoY), while the FY2025 annual figure was $427000.0, up 29.79% from the prior year.
- Current Leases was $316000.0 for Q1 2026 at Genelux, down from $427000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $653000.0 in Q4 2023 to a low of $266000.0 in Q4 2022.
- Historically, Current Leases has averaged $432363.6 across 5 years, with a median of $415000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Current Leases jumped 145.49% in 2023, then sank 49.62% in 2024.
- A 5-year view of Current Leases shows it stood at $266000.0 in 2022, then soared by 145.49% to $653000.0 in 2023, then tumbled by 49.62% to $329000.0 in 2024, then grew by 29.79% to $427000.0 in 2025, then retreated by 26.0% to $316000.0 in 2026.
- The last three Current Leases figures came in at $316000.0 (Q1 2026), $427000.0 (Q4 2025), and $354000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 316,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 354,000.00 |
| Jun 30, 2025 | 345,000.00 |
| Dec 31, 2024 | 329,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 584,000.00 |
| Dec 31, 2023 | 653,000.00 |
| Sep 30, 2023 | 567,000.00 |
| Dec 31, 2022 | 266,000.00 |